We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+5.37%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$747M
AUM Growth
-$1.07M
Cap. Flow
-$31.9M
Cap. Flow %
-4.27%
Top 10 Hldgs %
38.23%
Holding
234
New
17
Increased
62
Reduced
88
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 13.61%
2 Healthcare 7.47%
3 Consumer Discretionary 7.13%
4 Industrials 6.6%
5 Financials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUR icon
151
Murphy Oil
MUR
$5.48B
$337K 0.05%
11,100
TSLA icon
152
Tesla
TSLA
$1.22T
$329K 0.04%
24,165
CHKP icon
153
Check Point Software Technologies
CHKP
$13.1B
$327K 0.04%
4,216
GPC icon
154
Genuine Parts
GPC
$17.2B
$322K 0.04%
3,204
-300
-9% -$30.4K
AZN icon
155
AstraZeneca
AZN
$266B
$317K 0.04%
4,829
-75
-2% -$4.9K
ED icon
156
Consolidated Edison
ED
$40.4B
$309K 0.04%
4,103
+253
+7% +$19.7K
CMCSA icon
157
Comcast
CMCSA
$84B
$305K 0.04%
9,190
-510
-5% -$17K
SDY icon
158
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$305K 0.04%
3,612
PAYX icon
159
Paychex
PAYX
$41.4B
$298K 0.04%
5,148
+19
+0.4% +$1.14K
IWF icon
160
iShares Russell 1000 Growth ETF
IWF
$120B
$287K 0.04%
11,012
-2,312
-17% -$60.1K
XLNX
161
DELISTED
Xilinx Inc
XLNX
$285K 0.04%
5,246
-6,115
-54% -$314K
QQQ icon
162
Invesco QQQ Trust
QQQ
$450B
$274K 0.04%
2,304
+54
+2% +$6.23K
GILD icon
163
Gilead Sciences
GILD
$163B
$273K 0.04%
3,448
-1,002
-23% -$81.4K
WMT icon
164
Walmart Inc
WMT
$884B
$265K 0.04%
11,025
-525
-5% -$12.7K
IGSB icon
165
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$263K 0.04%
4,966
-200
-4% -$10.6K
MO icon
166
Altria Group
MO
$113B
$259K 0.03%
4,104
+160
+4% +$10.6K
NKE icon
167
Nike
NKE
$62.7B
$256K 0.03%
4,866
VTI icon
168
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
$256K 0.03%
2,296
-59
-3% -$6.54K
BBRC
169
DELISTED
Columbia Beyond BRICs ETF
BBRC
$245K 0.03%
15,160
-1,507
-9% -$24.2K
ABBV icon
170
AbbVie
ABBV
$455B
$244K 0.03%
+3,863
New +$250K
GSK icon
171
GSK
GSK
$104B
$244K 0.03%
4,522
+228
+5% +$12.5K
SHY icon
172
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$244K 0.03%
2,875
-428,578
-99% -$36.5M
VB icon
173
Vanguard Morningstar Small-Cap ETF
VB
$79.6B
$241K 0.03%
1,972
AFL icon
174
Aflac
AFL
$64.8B
$239K 0.03%
6,634
+200
+3% +$7.28K
DEO icon
175
Diageo
DEO
$49.5B
$237K 0.03%
2,044

Similar funds

Grimes & Company's Q3 2016 Portfolio in Review

As of Q3 2016, Grimes & Company held 234 positions worth $747M, down 0.14% from $748M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Grimes & Company withdrew a net $31.9M in Q3 2016, closing 28 positions and reducing 88 holdings. Its most notable exit was Rockwell Automation, an estimated $7.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Grimes & Company opened a new position in Novo Nordisk worth $8M.

  • Grimes & Company's largest Q3 2016 buy was Novo Nordisk: 384,724 shares worth $8M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q3 2016, an estimated $19.1M increase.
  • Grimes & Company's biggest Q3 2016 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $41.4M.
  • Grimes & Company fully exited Rockwell Automation in Q3 2016, selling an estimated $7.6M.
  • Grimes & Company's ten largest holdings make up 38% of its $747M portfolio in Q3 2016.
  • Grimes & Company opened 17 new positions and closed 28 in Q3 2016.
  • Grimes & Company's portfolio value fell 0.14% quarter-over-quarter to $747M.

Based on Grimes & Company's 13F filing for Q3 2016, filed 24 Oct 2016.